Liver Transplant Rejection
📧 Sign up to get email alerts when something new happens for Liver Transplant Rejection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-08-11FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for CellCEPT (mycophenolate mofetil) submitted by Genentech, updating regulatory status for addition…
-
FDA approval · 2021-08-11FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for mycophenolate mofetil submitted by Hikma Pharmaceuticals USA Inc., updating the product info…
-
FDA approval · 2021-08-11FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for mycophenolate mofetil submitted by Sandoz Inc.
-
FDA approval · 2021-08-11FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for mycophenolate mofetil from Accord Healthcare, resulting in updated product labeling.
-
FDA approval · 2021-08-11FDA Approved: MYCOPHENOLIC ACID — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for mycophenolic acid submitted by Apotex Corp.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-08-11FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for mycophenolate mofetil from Hikma Pharmaceuticals USA Inc., indicating an approved change to the …
-
FDA approval · 2021-08-11FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
The FDA approved a supplemental application for Mycophenolate mofetil (ANDA 065416) from Accord Healthcare Inc., updating the status of this…
-
FDA approval · 2021-08-11FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Mycophenolate mofetil from Mylan Pharmaceuticals Inc., updating the regulatory status for th…
-
FDA approval · 2021-08-11FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for Mycophenolate mofetil, submitted by Mylan Institutional LLC, potentially expanding labeling or i…
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: Budesonide for Liver Transplant Immune Suppression [Phase 2]
Phase 2 clinical trial evaluating budesonide for liver transplant immune suppression has completed with posted results.
-
FDA approval · 2021-07-16FDA Approved: PROGRAF — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for PROGRAF (tacrolimus) from Astellas Pharma US, expanding or updating its labeling and indications…
-
FDA approval · 2021-05-17FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Hikma's generic mycophenolate mofetil, authorizing its marketing for organ transplant rejection …
-
FDA approval · 2021-05-17FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for mycophenolate mofetil from Hikma Pharmaceuticals USA Inc., approving changes to the product'…
-
FDA approval · 2021-05-17FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for mycophenolate mofetil from Sandoz Inc.
-
FDA approval · 2021-05-17FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
FDA approves Accord Healthcare's supplemental application for mycophenolate mofetil. The generic product is approved for use in preventing o…
-
FDA approval · 2021-05-04FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for mycophenolate mofetil submitted by Mylan Pharmaceuticals, updating labeling and/or indicatio…
-
FDA approval · 2021-04-21FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for CELLCEPT (mycophenolate mofetil) from Genentech, Inc.
-
FDA approval · 2021-04-21FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for mycophenolate mofetil from Mylan Pharmaceuticals, indicating an approved change to the exist…
-
FDA approval · 2021-04-21FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for mycophenolate mofetil from Ascend Laboratories, LLC.
-
FDA approval · 2021-04-21FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (CONCORD BIOTECH LIMITED)
FDA approved a supplemental application for mycophenolate mofetil by Concord Biotech Limited, enabling continued marketing of the immunosupp…
-
FDA approval · 2021-04-21FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (VistaPharm, LLC)
The FDA approved a supplemental application for mycophenolate mofetil from VistaPharm, LLC, enabling continued marketing of a generic versio…
-
FDA approval · 2021-04-21FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for Mycophenolate mofetil from Strides Pharma Science Limited (ANDA 090055).
-
FDA approval · 2021-04-21FDA Approved: MYCOPHENOLIC ACID — Supplemental Application (Slate Run Pharmaceuticals, LLC)
FDA approved a supplemental application for mycophenolic acid from Slate Run Pharmaceuticals, LLC.
-
FDA approval · 2021-04-21FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for Mycophenolate mofetil (ANDA 203859) from Mylan Institutional LLC.
-
FDA approval · 2021-02-10FDA Approved: MYCOPHENOLIC ACID — Original Application (Slate Run Pharmaceuticals, LLC)
FDA approved a generic mycophenolic acid product (ANDA 214376) from Slate Run Pharmaceuticals for prophylaxis of organ transplant rejection …